Explore the details of the Theravance Biopharma R&D Ip, Llc V. Eugia Pharma Specialities Ltd. case under case number 1:25-cv-03790 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-03790
Filing Date
May 2, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
MYLAN IRELAND LIMITED -
THERAVANCE BIOPHARMA IRELAND LIMITED -
AUROBINDO PHARMA USA, INC. -
VIATRIS SPECIALTY LLC -
LIFESTAR PHARMA LLC -
CIPLA LIMITED -
MANKIND PHARMA LTD. -
EUGIA US LLC -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

May 2, 2025Judge Karen M. Williams and Magistrate Judge Ann Marie Donio added. (dmw)PACER Document
May 6, 2025Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (aji, )PACER Document